Proposed Data Collections Submitted for Public Comment and Recommendations, 13056-13057 [2014-04974]
Download as PDF
<![CDATA[
13056
Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices
burden is the specific request for a
clinical abstract of terminal illness and
final diagnosis relating to
pneumoconiosis. Therefore, only five
minutes of additional burden is
estimated for the pathologist’s report.
• Consent, Release and History Form
(2.6)—This form documents written
authorization from the next-of-kin to
perform an autopsy on the deceased
miner. A minimum of essential
information is collected regarding the
deceased miner including the
occupational history and smoking
history. From past experience, it is
estimated that 15 minutes is required for
the next-of-kin to complete this form.
There are no costs to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Coal Mine Operators .......................................
X-ray Facility Supervisor .................................
X-ray—Coal Miners .........................................
Coal Miners .....................................................
B Reader Physicians ......................................
Physicians taking the B Reader Examination
Spirometry Test—Coal Miners ........................
Pathologist ......................................................
Pathologist ......................................................
Next-of-kin for deceased miner ......................
Form 2.10 .......................................................
Form 2.11 .......................................................
No form required ............................................
Form 2.9 .........................................................
Form 2.8 .........................................................
Form 2.12 .......................................................
No form required ............................................
Invoice—No standard form ............................
Pathology Report—No standard form ............
Form 2.6 .........................................................
Leroy Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–04971 Filed 3–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Proposed Project
Centers for Disease Control and
Prevention
[60Day–14–0904]
mstockstill on DSK4VPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Leroy Richardson, 1600
Clifton Road, MS D–74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
VerDate Mar<15>2010
18:39 Mar 06, 2014
Jkt 232001
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
SEARCH for Diabetes in Youth Study
(OMB No. 0920–0904, exp. 11/30/
2014)—Revision—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Diabetes is one of the most common
chronic diseases among children in the
United States. When diabetes strikes
during childhood, it is routinely
assumed to be type 1, or juvenile-onset,
diabetes. Type 1 diabetes (T1D)
develops when the body’s immune
system destroys pancreatic cells that
make the hormone insulin. Type 2
diabetes begins when the body develops
a resistance to insulin and no longer
uses it properly. As the need for insulin
rises, the pancreas gradually loses its
ability to produce sufficient amounts of
insulin to regulate blood sugar. Reports
of increasing frequency of both type 1
and type 2 diabetes in youth have been
among the most concerning aspects of
the evolving diabetes epidemic. In
response to this growing public health
concern, the Centers for Disease Control
and Prevention (CDC) and the National
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
200
100
5,000
5,000
10,000
100
2,500
5
5
5
1
1
1
1
1
1
1
1
1
1
Average
burden/
response
(in hrs)
30/60
30/60
15/60
20/60
3/60
10/60
20/60
5/60
5/60
15/60
Institutes of Health (NIH) funded the
SEARCH for Diabetes in Youth Study.
The SEARCH for Diabetes in Youth
Study began in 2000 as a multi-center,
epidemiological study, conducted in six
geographically dispersed clinical study
centers that reflected the racial and
ethnic diversity of the U.S. Phases 1
(2000–2005) and 2 (2005–2010)
produced estimates of the prevalence
and incidence of diabetes among youth
age <20 years, according to diabetes
type, age, sex, and race/ethnicity, and
characterized selected acute and chronic
complications of diabetes and their risk
factors, as well as the quality of life and
quality of health care. In Phases 1 and
2, the clinical centers and a data
coordinating center were funded
through cooperative agreements. The
information collected at that time was
not provided directly to CDC.
Phase 3 (2011–present) builds upon
previous efforts. Five clinical sites
collect patient-level information that is
compiled by a data coordinating center.
CDC obtained OMB approval to receive
the information in 2011 (SEARCH for
Diabetes in Youth, OMB No. 0920–0904,
exp. 11/30/2014). Phase 3 includes a
case registry of youth <20 years of age
who have been diagnosed with diabetes,
and a longitudinal cohort research study
about SEARCH cases whose diabetes
was incident in 2002 or later. To date,
SEARCH Phase 3 has identified an
average of 1,361 incident cases of
diabetes among youth under 20 years
each year of the study and has
completed an average of 1,088
participant surveys each year (80%
participation rate among registry study
participants). As of November 2013,
E:\FR\FM\07MRN1.SGM
07MRN1
13057
Federal Register / Vol. 79, No. 45 / Friday, March 7, 2014 / Notices
SEARCH Phase 3 has completed visits
for 1,839 cohort study participants.
CDC plans to continue information
collection for two additional years, with
minor changes. Participants in the
registry study will continue to complete
a Medication Inventory and an Initial
Participant Survey; however, the inperson study examination will be
discontinued. This change will result in
a decrease in burden per respondent.
CDC estimates that each clinical site
will identify and register an average of
255 cases per year, for a total 1,275
cases across all sites.
No data collection changes are
planned for the cohort study. CDC
estimates that each clinical site will
conduct follow-up on an average of 142
cases per year, for a total of 710 cases
across all sites. The items collected for
each case include a Health
Questionnaire (Youth version), an
additional Health Questionnaire (Parent
version), Center for Epidemiologic
Study-Depression, Quality of Care,
Pediatric Quality of Life Survey (Peds
QL), SEARCH Michigan Neuropathy
Screening Instrument, Diabetes Eating
Survey, Low Blood Sugar Survey,
Supplemental Survey, Tanner Stage,
Retinal Photo, Family Conflict Survey,
Pediatric Diabetes Quality of Life Scale,
Physical Exam, Specimen Collection,
and Food Frequency Questionnaire.
Findings from the registry study will
be used to estimate the incidence of
diabetes in youth in the U.S. Findings
from the cohort study will be used to
estimate the prevalence and incidence
of risk factors and complications
associated with diabetes in youth,
including chronic microvascular
complications (retinopathy,
nephropathy, and autonomic
neuropathy) and selected markers of
macrovascular complications
(hypertension, arterial stiffness) of
diabetes.
Participation is voluntary and there
are no costs to respondents other than
their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hr)
Number of
responses per
respondent
Type of
respondents
Form name
SEARCH Registry Study Participants .....
Medication Inventory ..................
Initial Participant Survey ............
Health Questionnaire-Youth ......
Health Questionnaire-Parent .....
CES-Depression ........................
Quality of Care ...........................
Peds QL .....................................
SEARCH MNSI Neuropathy ......
Diabetes Eating Survey .............
Low Blood Sugar Survey ...........
Supplemental Survey .................
Tanner Stage .............................
Retinal Photo .............................
Family Conflict Survey ...............
Pediatric Diabetes QOL Scale ...
Physical Exam ...........................
Specimen Collection ..................
Food Frequency Questionnaire
1,275
1,275
710
710
710
710
710
710
710
710
710
710
710
710
710
710
710
710
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
5/60
10/60
15/60
15/60
4/60
13/60
5/60
10/60
5/60
5/60
10/60
5/60
15/60
5/60
5/60
3
20/60
20/60
106
213
178
178
47
154
59
118
59
59
118
59
178
59
59
2,130
237
237
....................................................
........................
........................
........................
4,248
SEARCH Cohort Study Participants .......
Total .................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–04974 Filed 3–6–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
[30Day–14–0138]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
18:39 Mar 06, 2014
Jkt 232001
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Centers for Disease Control and
Prevention
VerDate Mar<15>2010
Number of
respondents
Pulmonary Function Testing Course
Approval Program, 29 CFR 1910.1043
(OMB No. 0920–0138, Expiration 8/31/
2014)—Revision—The National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Total burden
(in hr)
Background and Brief Description
NIOSH has the responsibility under
the Occupational Safety and Health
Administration’s Cotton Dust Standard,
29 CFR 1920.1043, for approving
courses to train technicians to perform
pulmonary function testing in the cotton
industry. Successful completion of a
NIOSH-approved course is mandatory
under the standard.
To carry out its responsibility, NIOSH
maintains a Pulmonary Function
Testing Course Approval Program. The
program consists of an application
submitted by potential sponsors
(universities, hospitals, and private
consulting firms) who seek NIOSH
approval to conduct courses, and if
approved, notification to NIOSH of any
course or faculty changes during the
approval period, which is limited to five
years. The application form and added
materials, including an agenda,
E:\FR\FM\07MRN1.SGM
07MRN1
]]>Agencies
[Federal Register Volume 79, Number 45 (Friday, March 7, 2014)]
[Notices]
[Pages 13056-13057]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-04974]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-0904]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570 or
send comments to Leroy Richardson, 1600 Clifton Road, MS D-74, Atlanta,
GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
SEARCH for Diabetes in Youth Study (OMB No. 0920-0904, exp. 11/30/
2014)--Revision--National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
Diabetes is one of the most common chronic diseases among children
in the United States. When diabetes strikes during childhood, it is
routinely assumed to be type 1, or juvenile-onset, diabetes. Type 1
diabetes (T1D) develops when the body's immune system destroys
pancreatic cells that make the hormone insulin. Type 2 diabetes begins
when the body develops a resistance to insulin and no longer uses it
properly. As the need for insulin rises, the pancreas gradually loses
its ability to produce sufficient amounts of insulin to regulate blood
sugar. Reports of increasing frequency of both type 1 and type 2
diabetes in youth have been among the most concerning aspects of the
evolving diabetes epidemic. In response to this growing public health
concern, the Centers for Disease Control and Prevention (CDC) and the
National Institutes of Health (NIH) funded the SEARCH for Diabetes in
Youth Study.
The SEARCH for Diabetes in Youth Study began in 2000 as a multi-
center, epidemiological study, conducted in six geographically
dispersed clinical study centers that reflected the racial and ethnic
diversity of the U.S. Phases 1 (2000-2005) and 2 (2005-2010) produced
estimates of the prevalence and incidence of diabetes among youth age
<20 years, according to diabetes type, age, sex, and race/ethnicity,
and characterized selected acute and chronic complications of diabetes
and their risk factors, as well as the quality of life and quality of
health care. In Phases 1 and 2, the clinical centers and a data
coordinating center were funded through cooperative agreements. The
information collected at that time was not provided directly to CDC.
Phase 3 (2011-present) builds upon previous efforts. Five clinical
sites collect patient-level information that is compiled by a data
coordinating center. CDC obtained OMB approval to receive the
information in 2011 (SEARCH for Diabetes in Youth, OMB No. 0920-0904,
exp. 11/30/2014). Phase 3 includes a case registry of youth <20 years
of age who have been diagnosed with diabetes, and a longitudinal cohort
research study about SEARCH cases whose diabetes was incident in 2002
or later. To date, SEARCH Phase 3 has identified an average of 1,361
incident cases of diabetes among youth under 20 years each year of the
study and has completed an average of 1,088 participant surveys each
year (80% participation rate among registry study participants). As of
November 2013,
[[Page 13057]]
SEARCH Phase 3 has completed visits for 1,839 cohort study
participants.
CDC plans to continue information collection for two additional
years, with minor changes. Participants in the registry study will
continue to complete a Medication Inventory and an Initial Participant
Survey; however, the in-person study examination will be discontinued.
This change will result in a decrease in burden per respondent. CDC
estimates that each clinical site will identify and register an average
of 255 cases per year, for a total 1,275 cases across all sites.
No data collection changes are planned for the cohort study. CDC
estimates that each clinical site will conduct follow-up on an average
of 142 cases per year, for a total of 710 cases across all sites. The
items collected for each case include a Health Questionnaire (Youth
version), an additional Health Questionnaire (Parent version), Center
for Epidemiologic Study-Depression, Quality of Care, Pediatric Quality
of Life Survey (Peds QL), SEARCH Michigan Neuropathy Screening
Instrument, Diabetes Eating Survey, Low Blood Sugar Survey,
Supplemental Survey, Tanner Stage, Retinal Photo, Family Conflict
Survey, Pediatric Diabetes Quality of Life Scale, Physical Exam,
Specimen Collection, and Food Frequency Questionnaire.
Findings from the registry study will be used to estimate the
incidence of diabetes in youth in the U.S. Findings from the cohort
study will be used to estimate the prevalence and incidence of risk
factors and complications associated with diabetes in youth, including
chronic microvascular complications (retinopathy, nephropathy, and
autonomic neuropathy) and selected markers of macrovascular
complications (hypertension, arterial stiffness) of diabetes.
Participation is voluntary and there are no costs to respondents
other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
----------------------------------------------------------------------------------------------------------------
SEARCH Registry Study Medication 1,275 1 5/60 106
Participants. Inventory. 1,275 1 10/60 213
Initial
Participant
Survey.
SEARCH Cohort Study Health 710 1 15/60 178
Participants. Questionnaire- 710 1 15/60 178
Youth.
Health
Questionnaire-
Parent.
CES-Depression.. 710 1 4/60 47
Quality of Care. 710 1 13/60 154
Peds QL......... 710 1 5/60 59
SEARCH MNSI 710 1 10/60 118
Neuropathy.
Diabetes Eating 710 1 5/60 59
Survey.
Low Blood Sugar 710 1 5/60 59
Survey.
Supplemental 710 1 10/60 118
Survey.
Tanner Stage.... 710 1 5/60 59
Retinal Photo... 710 1 15/60 178
Family Conflict 710 1 5/60 59
Survey.
Pediatric 710 1 5/60 59
Diabetes QOL
Scale.
Physical Exam... 710 1 3 2,130
Specimen 710 1 20/60 237
Collection.
Food Frequency 710 1 20/60 237
Questionnaire.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 4,248
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-04974 Filed 3-6-14; 8:45 am]
BILLING CODE 4163-18-P
